#BEGIN_DRUGCARD DB08775

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C21H24N2O5

# Chemical_IUPAC_Name:
benzyl N-[(1S)-2-(4-hydroxyphenyl)-1-{[(2S)-3-oxobutan-2-yl]carbamoyl}ethyl]carbamate

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:34:50 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
BENZOYL-TYROSINE-ALANINE-METHYL KETONE

# HET_ID:
ZYA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C21H24N2O5/c1-14(15(2)24)22-20(26)19(12-16-8-10-18(25)11-9-16)23-21(27)28-13-17-6-4-3-5-7-17/h3-11,14,19,25H,12-13H2,1-2H3,(H,22,26)(H,23,27)/t14-,19-/m0/s1

# InChI_Key:
InChIKey=CLDDOKCDXBMMKZ-LIRRHRJNSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8781

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
384.4257

# Molecular_Weight_Mono:
384.168521888

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.47

# Predicted_LogS:
-4.3

# Predicted_Water_Solubility:
1.82e-02 g/l

# Primary_Accession_No:
DB08775

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](C)(NC(=O)[C@]([H])(CC1=CC=C(O)C=C1)NC(=O)OCC1=CC=CC=C1)C(C)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:27:15 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Lysosome

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CTSF

# Drug_Target_1_GenBank_ID_Gene:
AJ007331

# Drug_Target_1_GenBank_ID_Protein:
4826528

# Drug_Target_1_GeneCard_ID:
CTSF

# Drug_Target_1_Gene_Name:
CTSF

# Drug_Target_1_Gene_Sequence:
>1455 bp
ATGGCGCCCTGGCTGCAGCTCCTGTCGCTGCTGGGGCTGCTCCCGGGCGCAGTGGCCGCC
CCCGCCCAGCCCCGAGCCGCCAGCTTTCAGGCCTGGGGGCCGCCGTCCCCGGAGCTGCTG
GCGCCCACCCGCTTCGCGCTGGAGATGTTCAACCGCGGCCGGGCTGCGGGGACGCGGGCC
GTGCTGGGCCTTGTGCGCGGCCGCGTCCGCCGGGCGGGTCAGGGGTCGCTGTACTCCCTG
GAGGCCACCCTGGAGGAGCCACCCTGCAACGACCCCATGGTGTGCCGGCTCCCCGTGTCC
AAGAAAACCCTGCTCTGCAGCTTCCAAGTCCTGGATGAGCTCGGAAGACACGTGCTGCTG
CGGAAGGACTGTGGCCCAGTGGACACCAAGGTTCCAGGTGCTGGGGAGCCCAAGTCAGCC
TTCACTCAGGGCTCAGCCATGATTTCTTCTCTGTCCCAAAACCATCCAGACAACAGAAAC
GAGACTTTCAGCTCAGTCATTTCCCTGTTGAATGAGGATCCCCTGTCCCAGGACTTGCCT
GTGAAGATGGCTTCAATCTTCAAGAACTTTGTCATTACCTATAACCGGACATATGAGTCA
AAGGAAGAAGCCCGGTGGCGCCTGTCCGTCTTTGTCAATAACATGGTGCGAGCACAGAAG
ATCCAGGCCCTGGACCGTGGGACAGCTCAGTATGGAGTCACCAAGTTCAGTGATCTCACA
GAGGAGGAGTTCCGCACTATCTACCTGAATACTCTCCTGAGGAAAGAGCCTGGCAACAAG
ATGAAGCAAGCCAAGTCTGTGGGTGACCTCGCCCCACCTGAATGGGACTGGAGGAGTAAG
GGGGCTGTCACAAAAGTCAAAGACCAGGGCATGTGTGGCTCCTGCTGGGCCTTCTCAGTC
ACAGGCAATGTGGAGGGCCAGTGGTTTCTCAACCAGGGGACCCTGCTCTCCCTCTCTGAA
CAGGAGCTCTTGGACTGTGACAAGATGGACAAGGCCTGCATGGGCGGCTTGCCCTCCAAT
GCCTACTCGGCCATAAAGAATTTGGGAGGGCTGGAGACAGAGGATGACTACAGCTACCAG
GGTCACATGCAGTCCTGCAACTTCTCAGCAGAGAAGGCCAAGGTCTACATCAATGACTCC
GTGGAGCTGAGCCAGAACGAGCAGAAGCTGGCAGCCTGGCTGGCCAAGAGAGGCCCAATC
TCCGTGGCCATCAATGCCTTTGGCATGCAGTTTTACCGCCACGGGATCTCCCGCCCTCTC
CGGCCCCTCTGCAGCCCTTGGCTCATTGACCATGCGGTGTTGCTTGTGGGCTACGGCAAC
CGCTCTGACGTTCCCTTTTGGGCCATCAAGAACAGCTGGGGCACTGACTGGGGTGAGAAG
GGTTACTACTACTTGCATCGTGGGTCCGGGGCCTGTGGCGTGAACACCATGGCCAGCTCG
GCGGTGGTGGACTGA

# Drug_Target_1_General_Function:
Involved in cysteine-type endopeptidase activity

# Drug_Target_1_General_References:
10198209	Nagler DK, Sulea T, Menard R: Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen. Biochem Biophys Res Commun. 1999 Apr 13;257(2):313-8.
10318784	Santamaria I, Velasco G, Pendas AM, Paz A, Lopez-Otin C: Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J Biol Chem. 1999 May 14;274(20):13800-9.
10362521	Wex T, Levy B, Wex H, Bromme D: Human cathepsins F and W: A new subgroup of cathepsins. Biochem Biophys Res Commun. 1999 Jun 7;259(2):401-7.
10661872	Wex T, Wex H, Bromme D: The human cathepsin F gene--a fusion product between an ancestral cathepsin and cystatin gene. Biol Chem. 1999 Dec;380(12):1439-42.
9822672	Wang B, Shi GP, Yao PM, Li Z, Chapman HA, Bromme D: Human cathepsin F. Molecular cloning, functional expression, tissue localization, and enzymatic characterization. J Biol Chem. 1998 Nov 27;273(48):32000-8.

# Drug_Target_1_HGNC_ID:
HGNC:2531

# Drug_Target_1_HPRD_ID:
04643

# Drug_Target_1_ID:
2735

# Drug_Target_1_Locus:
11q13

# Drug_Target_1_Molecular_Weight:
53366

# Drug_Target_1_Name:
Cathepsin F

# Drug_Target_1_Number_of_Residues:
484

# Drug_Target_1_PDB_ID:
1M6D

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00112	Peptidase_C1
PF08246	Inhibitor_I29

# Drug_Target_1_Protein_Sequence:
>Cathepsin F precursor
MAPWLQLLSLLGLLPGAVAAPAQPRAASFQAWGPPSPELLAPTRFALEMFNRGRAAGTRA
VLGLVRGRVRRAGQGSLYSLEATLEEPPCNDPMVCRLPVSKKTLLCSFQVLDELGRHVLL
RKDCGPVDTKVPGAGEPKSAFTQGSAMISSLSQNHPDNRNETFSSVISLLNEDPLSQDLP
VKMASIFKNFVITYNRTYESKEEARWRLSVFVNNMVRAQKIQALDRGTAQYGVTKFSDLT
EEEFRTIYLNTLLRKEPGNKMKQAKSVGDLAPPEWDWRSKGAVTKVKDQGMCGSCWAFSV
TGNVEGQWFLNQGTLLSLSEQELLDCDKMDKACMGGLPSNAYSAIKNLGGLETEDDYSYQ
GHMQSCNFSAEKAKVYINDSVELSQNEQKLAAWLAKRGPISVAINAFGMQFYRHGISRPL
RPLCSPWLIDHAVLLVGYGNRSDVPFWAIKNSWGTDWGEKGYYYLHRGSGACGVNTMASS
AVVD

# Drug_Target_1_Reaction:
The recombinant enzyme cleaves synthetic substrates with Phe and Leu (better than Val) in P2, with high specificity constant (kcat/Km) comparable to that of cathepsin L

# Drug_Target_1_Signals:
1-19

# Drug_Target_1_Specific_Function:
Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Has also been implicated in tumor invasion and metastasis

# Drug_Target_1_SwissProt_ID:
Q9UBX1

# Drug_Target_1_SwissProt_Name:
CATF_HUMAN

# Drug_Target_1_Synonyms:
CATSF
Cathepsin F precursor
EC 3.4.22.41

# Drug_Target_1_Theoretical_pI:
8.33

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB08775
